Osaic Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Osaic Holdings's EW Position: Q2 2026 in Review
Osaic Holdings increased its Edwards Lifesciences (EW) stake by 39% in Q2 2026, buying an estimated $1.36M and bringing the position to 57,651 shares worth $5.22M. The position accounts for 0.01% of the portfolio, ranked #1498.
Osaic Holdings first reported a position in EW in Q1 2020 and has held it in 26 quarters since. The position peaked at $28.9M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Osaic Holdings held 57,651 shares of Edwards Lifesciences worth $5.22M as of Q2 2026.
- Osaic Holdings bought 16,235 Edwards Lifesciences shares in Q2 2026, an estimated $1.36M.
- Edwards Lifesciences made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1498 holding.
- Osaic Holdings first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Edwards Lifesciences position peaked at $28.9M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.